SEC Form 4 · accession 0001235802-17-000023
ENTELLUS MEDICAL INC · ENTL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Period of report
Jan 31, 2017
Accepted (ET)
Feb 2, 2017 · 4:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001374128
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par valueF1,F2,F3 | Jan 31, 2017 | S | 527,022 | $17.00 | D | 2,928,689 | I | By Fund VIII |
| Common Stock, $0.001 par valueF1,F2,F3 | Jan 31, 2017 | S | 37,998 | $17.00 | D | 211,159 | I | By Fund VIII-A |
| Common Stock, $0.001 par valueF1,F2,F3 | Jan 31, 2017 | S | 16,521 | $17.00 | D | 91,808 | I | By Fund VIII-B |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a public offering price of $17.00 per share before underwriting discounts and commissions pursuant to an Underwriting Agreement dated January 25, 2017, which offering closed on January 31, 2017.
- F2See Exhibit 99.1.
- F3Each individual Manager and the General Partner disclaims beneficial ownership over the shares except to the extent of his or its respective pecuniary interest therein.